Find verified Regorafenib API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Regorafenib for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Regorafenib API.
Alternate Names: Stivarga, Regorafenibum
CAS No: 755037-03-7
PubChem CID: 11167602
Mol Formula: C21H15ClF4N4O3
Mol Weight: 482.8 g/mol
IUPAC Name: 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
API Description: Regorafenib is an orally-administered inhibitor of multiple kinases. It is used for the treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumours, and hepatocellular carcinoma. FDA approved on September 27, 2012. Approved use of Regorafenib was expanded to treat Hepatocellular Carcinoma in April 2017.
